Nonetheless, considering molecular genetic markers, we observed both IDH-mt diffuse astrocytoma and IDH-mt glioblastomas had significantly decreased levels of serum miR-4297 in comparison with IDH-wt gliomas. This evidence concerns the gene IDH1 and glioblastoma.